These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7887633)

  • 1. [Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].
    Ohkoshi M
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):417-30. PubMed ID: 7887633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serine protease inhibitor FOY-305 and heparin on the growth of squamous cell carcinoma.
    Ohkoshi M; Akagawa T; Nakajima M
    Anticancer Res; 1993; 13(4):963-6. PubMed ID: 8352567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic activity of a synthetic serine protease inhibitor, FOY-305 (Foypan).
    Ohkoshi M; Sasaki Y
    In Vivo; 2005; 19(1):133-6. PubMed ID: 15796165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
    Ohkoshi M; Fujii S
    Gan; 1982 Feb; 73(1):108-10. PubMed ID: 7117738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin.
    Ohkoshi M; Fujii S
    J Natl Cancer Inst; 1983 Nov; 71(5):1053-7. PubMed ID: 6580482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
    Ohkoshi M
    Gan; 1981 Dec; 72(6):959-64. PubMed ID: 7341342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of FOY-305 on liver metastasis of the pancreatic cancer].
    Ohta T; Futagami F; Arakawa H; Tsukioka Y; Kitagawa H; Kayahara M; Nagakawa T; Miyazaki I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1669-72. PubMed ID: 8886041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
    Ohkoshi M; Fujii S
    J Dermatol; 1984 Feb; 11(1):21-4. PubMed ID: 6376571
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth inhibition of mouse autochthonous skin cancer by oral administration of new serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2002; 22(2A):821-3. PubMed ID: 12014657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Lozonschi L; Sunamura M; Kobari M; Egawa S; Ding L; Matsuno S
    Cancer Res; 1999 Mar; 59(6):1252-8. PubMed ID: 10096556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of mouse skin tumor by serine protease inhibitor ONO-3403.
    Ohkoshi M; Okuda S
    Anticancer Res; 2001; 21(3B):1803-8. PubMed ID: 11497262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carcinogenic effects of a serine protease inhibitor (FOY-305) through the suppression of neutral serine protease activity during chemical hepatocarcinogenesis in rats.
    Yamauchi Y; Kobayashi M; Watanabe A
    Hiroshima J Med Sci; 1987 Mar; 36(1):81-7. PubMed ID: 2884198
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma.
    Ohkoshi M; Oka T
    J Maxillofac Surg; 1984 Aug; 12(4):148-52. PubMed ID: 6590712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin B in the growth of colorectal cancer: suppressive effect of leupeptin on the growth of DMH-induced rat colon neoplasm.
    Satoh Y; Higashi T; Nouso K; Shiota T; Kinugasa N; Yoshida K; Uematsu S; Nakatsukasa H; Nishimura Y; Tsuji T
    Acta Med Okayama; 1996 Dec; 50(6):299-303. PubMed ID: 8985466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY
    J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
    Shinoda K; Shibuya M; Hibino S; Ono Y; Matsuda K; Takemura A; Zou D; Kokubo Y; Takechi A; Kudoh S
    Int J Oncol; 2003 Feb; 22(2):281-8. PubMed ID: 12527923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.
    Palumbo JS; Potter JM; Kaplan LS; Talmage K; Jackson DG; Degen JL
    Cancer Res; 2002 Dec; 62(23):6966-72. PubMed ID: 12460914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor.
    Ikeda T; Murakami K; Hayakawa Y; Fujii H; Ohkoshi M; Saiki I
    Anticancer Res; 1998; 18(6A):4259-65. PubMed ID: 9891476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.